Use of telmisartan for the prevention and treatment of vascular headache

a technology of telmisartan and vascular headache, which is applied in the field of use, can solve the problems of compound interaction with the renin-angiotensin system, migraine pathophysiology is still unknown, and the treatment is not easy, and achieves the effect of high efficacy and favorable prophylaxis of vascular headaches
US20050065094A1Inactive Publication Date: 2005-03-24BOEHRINGER INGELHEIM INT GMBH

Patent Information

Authority / Receiving Office
US Ā· United States
Current Assignee / Owner
BOEHRINGER INGELHEIM INT GMBH
Publication Date
2005-03-24
Estimated Expiration
Not applicable Ā· inactive patent

Smart Images

  • Figure 1
    Figure 1
  • Figure 2
    Figure 2
Patent Text Reader

Abstract

The present invention relates to a method for the prophylaxis of vascular headaches which do not originate from hypertension, especially migraine, the method comprising administration of telmisartan to a subject in need of such a treatment. The present invention relates also to a method for the prophylaxis of vascular headaches, comprising the co-administration of telmisartan in combination with other drugs suitable for migraine prophylaxis and / or acute treatment of migraine.
Need to check novelty before this filing date? Find Prior Art

Description

FIELD OF THE INVENTION The present invention relates to a method for the prophylaxis of vascular headaches which do not originate from hypertension, especially migraine, the method comprising administration of {4′-[2-n-propyl-4-methyl-6-(1-methylbenzimidazol-2-yl)benzimidazol-1-ylmethyl]biphenyl-2-carboxylic acid} (telmisartan) to a subject in need of such a treatment. The present invention relates also to a method for the prophylaxis of vascular headaches, comprising the co-administration of telmisartan in combination with other drugs suitable for migraine prophylaxis and / or acute treatment of migraine. The invention further relates to suitable pharmaceutical compositions comprising telmisartan and at least one other drug used in migraine prophylaxis, as a combined preparation for simultaneous, separate or sequential use in the prophylaxis of said disease. The invention relates further to the use of telmisartan, optionally in combination with said other antimigraine drugs for the...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More